Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells.
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells.
复制标题
DOI:
10.1038/nature17665
复制
发表时间:
2016-04-28
期刊:
影响因子:
64.8
通讯作者:
Hope KJ
中科院分区:
文献类型:
--
作者:
Rentas S;Holzapfel N;Belew MS;Pratt G;Voisin V;Wilhelm BT;Bader GD;Yeo GW;Hope KJ
Umbilical cord blood (CB)-derived hematopoietic stem cells (HSCs) are essential in many life saving regenerative therapies, but their low number in CB units has significantly restricted their clinical use despite the advantages they provide during transplantation. Select small molecules that enhance hematopoietic stem and progenitor cell (HSPC) expansion in culture have been identified, however, in many cases their mechanisms of action or the nature of the pathways they impinge on are poorly understood. A greater understanding of the molecular pathways that underpin the unique human HSC self-renewal program will facilitate the development of targeted strategies that expand these critical cell types for regenerative therapies. Whereas transcription factor networks have been shown to influence the self-renewal and lineage decisions of human HSCs, the post-transcriptional mechanisms guiding HSC fate have not been closely investigated. Here we show that overexpression of the RNA-binding protein (RBP) Musashi-2 (MSI2) induces multiple pro-self-renewal phenotypes, including a 17-fold increase in short-term repopulating cells and a net 23-fold ex vivo expansion of long-term repopulating HSCs. By performing a global analysis of MSI2-RNA interactions, we determined that MSI2 directly attenuates aryl hydrocarbon receptor (AHR) signaling through post-transcriptional downregulation of canonical AHR pathway components in CB HSPCs. Our study provides new mechanistic insight into RBP-controlled RNA networks that underlie the self-renewal process and give evidence that manipulating such networks ex vivo can provide a novel means to enhance the regenerative potential of human HSCs.